FDA Adverse Event Malfunction Summary report: N

ARCHITECT TOTAL PSA

MDR report key: 15393497 · Received September 9, 2022

Report

Report Number
3008344661-2022-00107
Event Type
Malfunction
Date Received
September 9, 2022
Date of Event
August 11, 2022
Report Date
November 8, 2022
Manufacturer
ABBOTT IRELAND
Product Code
MTF
PMA / PMN Number
P910007
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ALL AVAILABLE PATIENT INFORMATION IS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 7K70 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 6C06. AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Additional Manufacturer Narrative · 0

AFTER FURTHER EVALUATION, THE SUSPECT MEDICAL DEVICE WAS CHANGED FROM ARCHITECT TOTAL PSA, 07K70-35, ABBOTT IRELAND - SLIGO TO ARCHITECT I2000SR, 03M74-02, ABBOTT LABORATORIES - IRVING, TEXAS. MDR NUMBER 3016438761-2022-00515-00 HAS BEEN SUBMITTED AND ALL FURTHER INFORMATION WILL BE DOCUMENTED UNDER THAT MDR NUMBER. H3 OTHER TEXT : AFTER FURTHER EVALUATION, THE SUSPECT MEDICAL DEVICE WAS CHANGED FROM ARCHITECT TOTAL PSA, 07K70-35, ABBOTT IRELAND - SLIGO TO ARCHITECT I2000SR, 03M74-02, ABBOTT LABORATORIES - IRVING, TEXAS. MDR NUMBER 3016438761-2022-00515-00 HAS BEEN SUBMITTED AND ALL FURTHER INFORMATION WILL BE DOCUMENTED UNDER THAT MDR NUMBER.

Description of Event or Problem · 0

THE CUSTOMER REPORTED A FALSELY DECREASED ARCHITECT TOTAL PSA (PROSTATE SPECIFIC ANTIGEN) RESULT FOR A PATIENT WHILE USING THE ARCHITECT I2000SR ANALYZER. ON (B)(6) 2022, A PSA SAMPLE (SID (B)(6)) RESULT WAS > 100 NG/ML. THE SAMPLE WAS THEN AUTOMATICALLY DILUTED BY THE INSTRUMENT AND VALUE GENERATED TO BE < 0.08 NG/ML. SINCE THE CUSTOMER USES AUTO-VALIDATIONS OF RESULTS, THE < 0.08 NG/ML WAS RELEASED TO THE PATIENT. PATIENT/CLINICIAN QUESTIONED THE DECREASED RESULT AS IT DID NOT CORRELATE WITH THE PATIENT¿S CLINICAL PICTURE. A FRESH SAMPLE WAS COLLECTED FROM THE PATIENT AND RUN DIRECTLY WITH DILUTION PROTOCOL WHERE THE RESULT GENERATED A VALUE OF 540.665 NG/ML. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1139762 ARCHITECT TOTAL PSA TOTAL, PROSTATE SPECIFIC AG (NONCOMPLEXED/COMPLEXED) FOR DET OF PROSTATE CANCER MTF ABBOTT IRELAND 35138FN00

Patients

Seq Age Sex Outcome Treatment
1 Unknown ARC I2000SR INST, 03M74-02, (B)(6) | ARC I2000SR INST, 03M74-02, (B)(6)